May 12, 2021
Using AI to Provide New Insights into Intentional Dose Non-Adherence
Inadvertent and intentional dose non-adherence in clinical trials has been a major drug development challenge for decades. Studies in the literature have demonstrated that a high percentage of study volunteers — as high as 75% — conceal or fabricate information and provide inaccurate self-reports of adherence.
